These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8355584)

  • 1. Time response of cholesterol synthesis inhibition by compactin-related compounds. In vitro quantitation of the "escape phenomenon".
    Sviridov DD; Endo A; Pavlov MY; Repin VS
    Lipids; 1993 Jun; 28(6):569-71. PubMed ID: 8355584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types.
    Sviridov DD; Endo A; Pavlov MYu ; Repin VS; Smirnov VN
    Lipids; 1990 Nov; 25(11):685-90. PubMed ID: 2280672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cholesterol synthesis by lovastatin tested on six human cell types in vitro.
    Sviridov DD; Safonova IG; Pavlov MY; Kosykh VA; Podrez EA; Antonov AS; Fuki IV; Repin VS
    Lipids; 1990 Mar; 25(3):177-9. PubMed ID: 2159099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages.
    Traber MG; Kayden HJ
    Atherosclerosis; 1984 Jul; 52(1):1-11. PubMed ID: 6087838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor.
    Fairbanks KP; Witte LD; Goodman DS
    J Biol Chem; 1984 Feb; 259(3):1546-51. PubMed ID: 6693424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of synthesis and cell content of the low-density-lipoprotein receptor protein in cultured fibroblasts from normal and familial hypercholesterolaemic subjects.
    Knight BL; Patel DD; Soutar AK
    Eur J Biochem; 1987 Feb; 163(1):189-96. PubMed ID: 3816797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Fears R; Richards DH; Ferres H
    Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 12. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.
    Betteridge DJ; Krone W; Reckless JP; Galton DJ
    Lancet; 1978 Dec 23-30; 2(8104-5):1342-3. PubMed ID: 82843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oleate and compactin on the metabolism and secretion of cholesterol and cholesteryl ester by rat hepatocytes.
    Pullinger CR; Gibbons GF
    Biochim Biophys Acta; 1982 Nov; 713(2):323-32. PubMed ID: 6960928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity.
    Oram JF; Albers JJ; Cheung MC; Bierman EL
    J Biol Chem; 1981 Aug; 256(16):8348-56. PubMed ID: 6267041
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of low-density lipoprotein and compactin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, on the synthesis of dolichol-linked oligosaccharides and low-density-lipoprotein receptor in human skin fibroblasts.
    Filipovic I; Menzel B
    Biochem J; 1981 May; 196(2):625-8. PubMed ID: 6274316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin-induced decrease of intracellular cholesterol level attenuates fibroblast-to-myofibroblast transition in bronchial fibroblasts derived from asthmatic patients.
    Michalik M; Soczek E; Kosińska M; Rak M; Wójcik KA; Lasota S; Pierzchalska M; Czyż J; Madeja Z
    Eur J Pharmacol; 2013 Mar; 704(1-3):23-32. PubMed ID: 23485731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
    Maxwell RE; Nawrocki JW; Uhlendorf PD
    Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
    Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T
    Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.